Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 3, 2013, Pages 256-259

  Gundlapalli, Adi V ^a,b   Beekmann, Susan E ^c   Graham, Donald R ^d   Polgreen, Philip M ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Springfield Clinic   (United States)

Author keywords

Antimicrobial agents; Communication; Drug shortages; Legislation; Patient outcomes

Indexed keywords

ACICLOVIR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; AZTREONAM; BENZATHINE PENICILLIN; CAPREOMYCIN; CEFAZOLIN; CEFOTETAN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN LACTOBIONATE; FOSCARNET; IMMUNOGLOBULIN; INFLUENZA VACCINE; OSELTAMIVIR; PENICILLIN G; POSACONAZOLE; SULTAMICILLIN; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE;

ARTICLE; DRUG CHOICE; DRUG MARKETING; DRUG SHORTAGE; DRUG UTILIZATION; HUMAN; INTERNET; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; PHARMACY; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

AMIKACIN; ANTI-INFECTIVE AGENTS; AZTREONAM; COMMUNICABLE DISEASES; DELIVERY OF HEALTH CARE; DRUG SUBSTITUTION; FOSCARNET; HEALTH CARE SURVEYS; HUMANS; PHARMACY SERVICE, HOSPITAL; PHYSICIANS; SOCIETIES, MEDICAL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84873729541     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.11.020     Document Type: Article

References (23)

1. Drug Shortages Resource Center American Society of Health-Systems Pharmacists, [cited 2011 Jul 31]; Available from:. http://www.ashp.org/menu/PracticePolicy/ResourceCenters/DrugShortages.aspx.
2. Drug Shortages Resource Center. American Society of Health-Systems Pharmacists American Society of Health-Systems Pharmacists, [cited 2012 Jul 14]; Available from. http://www.ashp.org/menu/PracticePolicy/ResourceCenters/DrugShortages.aspx.
3. Canadian Drug Shortages Survey FINAL REPORT2010 Canadian Pharmacists Association, Available from:. http://www.pharmacists.ca/cpha-ca/assets/file/cpha-on-the-issues/drugshortagesreport.pdf.
4. Freire-Moran L., et al. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat 2011, 14(2):118-124.
5. Griffith M.M., et al. The impact of anti-infective drug shortages on hospitals in the United States: trends and causes. Clin Infect Dis 2012, 54(5):684-691.
6. Griffith M.M., et al. Prospective approach to managing antimicrobial drug shortages. Infect Control Hosp Epidemiol 2012, 33(7):745-752.
7. Griffith M.M., et al. Antimicrobial drug shortages: a crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects. Pharmacotherapy 2012, [Epub 2012/06/30].
8. Hampton T. Experts look for ways to lessen impact of drug shortages and discontinuations. JAMA 2007, 298(7):727-728.
9. Harbarth S., et al. Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre. Int J Antimicrob Agents 2003, 21(5):484-487.
10. Emerging Infections Network Infectious Diseases Society of America, [cited July 29, 2011]; Available from:. http://ein.idsociety.org/.
11. Institutes for Healthcare Improvement Drug shortages: a patient safety crisis. Healthcare Executive 2011, 26(5):80-83.
12. Jensen V., Rappaport B.A. The reality of drug shortages-the case of the injectable agent propofol. N Engl J Med 2010, 363(9):806-807.
13. Kaakeh R., et al. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm 2011, 68(19):1811-1819.
14. One Hundred Twelfth Congress of the United States of America Food and Drug Administration Safety and Innovation Act 2012, 1-140. US Government, Washington DC. US Congress (Ed.).
15. Pluss-Suard C., et al. Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis. Antimicrob Agents Chemother 2012, 56(2):989-994.
16. Pulcini C., et al. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis 2012, 54(2):268-274.
17. Sparling P.F. Shortages of antibiotics, antivirals, and vaccines threaten the public health. Clin Infect Dis 2001, 33(9):1502-1503.
18. Spellberg B., et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011, 52(Suppl. 5):S397-S428.
19. Steinbrook R. Drug shortages and public health. N Engl J Med 2009, 361(16):1525-1527.
20. Strausbaugh L.J., et al. National shortages of antimicrobial agents: results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network. Clin Infect Dis 2001, 33(9):1495-1501.
21. ESGAP's RESPONSE TO THE EUROPEAN COMMISSION'S CONSULTATION on "The Future of Pharmaceuticals for Human Use in Europe" The ESCMID Study Group for Antibiotic Policies ESGAP, [cited 2011 Jul 29]; Available from:. http://www.escmid.org/fileadmin/src/media/PDFs/2News_Discussions/2Position_Papers/ESGAP_Position_Paper_on_Antibiotic_Drug_Shortage.pdf.
22. US Food and Drug Administration A review of FDA's approach to medical product shortages. US Deparment of Health and Human Services 2011, 1-44.
23. US Food and Drug Administration Current Drug Shortages [cited 2012 Jul 14]; Available from:. http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050792.htm.